Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain

Part of paid clinical trials in Mobile, Alabama.

Sponsor
University of Pittsburgh
Study ID
NCT06374238
Status
Recruiting

Conditions

Eligibility Criteria

Sex
ALL
Age
16 Years - 30 Years
Healthy Volunteers
Not accepted

Interventions

  • CBT+ Health coach — BEHAVIORAL
    Participants will complete the pre-enrollment clinical screening measures (PHQ-9M, GAD-7, and PEG-3) and will repeat those assessments, as well as outcome assessments, at 3 months, 6 months, and 12 months. Participants in CBT w/ Health coach group will engage with the CaRISMA app to complete a daily pain and mood e-diary, daily record of opiate use, and weekly assessment of pain via the Painimation tool. In addition participants will have weekly contact with a peer health coach.
  • CBT w/o Health Coach ( self-guided) — BEHAVIORAL
    Participants will complete the pre-enrollment clinical screening measures (PHQ-9M, GAD-7, and PEG-3) and will repeat those assessments, as well as outcome assessments, at 3 months, 6 months, and 12 months. Participants CBT w/o Health coach groups will engage with the CaRISMA app to complete a daily pain and mood e-diary, daily record of opiate use, and weekly assessment of pain via the Painimation tool.
  • Usual Care — BEHAVIORAL
    Participants will complete the pre-enrollment clinical screening measures (PHQ-9M, GAD-7, and PEG-3) and will repeat those assessments, as well as outcome assessments, at 3 months, 6 months, and 12 months. Participants in the UC group will be asked to engage with the CaRISMA app to complete a daily pain and mood e-diary, daily record of opiate use, and weekly assessment of pain via the Painimation tool. All other care will be at the discretion of their treating provider

Study Details

The study, known as the Peer suppoRt for adolescents and Emerging adults with Sickle cell pain: promoting ENgagement in Cognitive behavioral thErapy (PRESENCE), aims to determine the effectiveness of digital CBT in reducing pain, opioid use, and healthcare utilization among AYAs with SCD. It also seeks to understand the role of personalized peer support in enhancing engagement and outcomes of digital CBT interventions. By leveraging existing infrastructure for delivering virtual peer support interventions, tailored digital CBT programs for individuals with SCD, and partnerships with CBOs, the study aims to provide valuable insights into the feasibility and effectiveness of digital CBT as a pain management strategy for this vulnerable population.

Key Dates

Start date
Mar 10, 2025
Status verified
Sep 2025
Primary completion
Jul 31, 2027
Completion
May 31, 2028

Study Design

Enrollment
470 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: CBT w/ Health Coach
    Group will utilize the Presence app to undergo self CBT for EMA, but with addition of peer health coaches.
  • Active Comparator: CBT w/o Health coach (self-guided)
    Group will utilize the Presence app to undergo self-guided CBT for EMA, but without peer health coaches.
  • Active Comparator: Usual Care with no access to CBT
    Participants in the UC group will have access to CaRISMA app to complete a daily pain and mood e-diary, daily record of opiate use, and weekly assessment of pain via the Painimation tool. All other care will be at the discretion of their treating provider

Primary Outcome Measure

Determine the effectiveness of any digital CBT (CBT + peer or self-guided CBT) vs usual care (UC) to improve pain intensity for AYAs with SCD and chronic pain [ Time Frame: Baseline and 6 months ]

Central Contacts

Locations (14)

FacilityCityStateZIPSite coordinators
University of South Alabama Medical CenterMobileAlabama36617
Jessica King
(251) 445-9159
T'Shemika Perryman
Antwan Hogue, MD (PRINCIPAL_INVESTIGATOR)
Ardie Pack-Mabien, PhD (SUB_INVESTIGATOR)
UCLA Mattel Children's Hospital Ronald Reagan HospitalLos AngelesCalifornia90095
Debbie Argueta Rufino
(424) 362-0037
Satiro De Oliveira, MD (PRINCIPAL_INVESTIGATOR)
Connecticut Children's Medical CenterHartfordConnecticut06106
Christopher Theriault
(860) 837-5852
William Zempsky, MD (PRINCIPAL_INVESTIGATOR)
Children's Healthcare of AtlantaAtlantaGeorgia30345
Katyria Thornton
(404) 785-6274
Vontarius Howard Jesse
(404) 785-3245
Carlton Dampier, MD (PRINCIPAL_INVESTIGATOR)
Ann and Robert H. Lurie Children's Hospital of ChicagoChicagoIllinois60611
Kevin Guerrero
(312) 227-4824
Robert Liem, MD (PRINCIPAL_INVESTIGATOR)
The Regents of the University of MichiganAnn ArborMichigan48109-1079
Anela Mukherjee
7342329896
Eric Scott, PhD (PRINCIPAL_INVESTIGATOR)
Rutgers New Jersey Medical SchoolNewarkNew Jersey07103
Kim White
(732) 277-7703
Ashwin Sridharan, MD (PRINCIPAL_INVESTIGATOR)
Weil Cornell Medical CollegeNew YorkNew York10065
Masiel Infante
646-962-8311
Maria DeSancho, MD (PRINCIPAL_INVESTIGATOR)
University of Rochester Medical CenterRochesterNew York14642
Priya Kaushal
(585) 275-2981
Suzie Noronha, MD (PRINCIPAL_INVESTIGATOR)
Wake Forest Baptist HospitalDurhamNorth Carolina27106
Julie Fountain
(980) 442-2000
Alex George, MD (PRINCIPAL_INVESTIGATOR)
East Carolina University Health Medical CenterGreenvilleNorth Carolina27834
Toria Wilson
(252) 744-0493
Darla Liles, MD (PRINCIPAL_INVESTIGATOR)
UPMC Children's Hospital of PittsburghPittsburghPennsylvania15224
Alex Berkebile
412-692-5964
Amy Travis
412-692-8575
Dr. Cheryl Hillery, MD (PRINCIPAL_INVESTIGATOR)
UPMC University of Pittsburgh Classical Hematology Adult ClinicPittsburghPennsylvania15213
Steffi Siebert, MPH
8776490176
Laura De Castro, MD (PRINCIPAL_INVESTIGATOR)
Ana Radovic, MD (PRINCIPAL_INVESTIGATOR)
Virginia Commonwealth UniversityRichmondVirginia23284
Danie Sop, PhD
(804) 828-0810
Wally Smith, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Mobile, AL

Related Studies